Novavax expects Omicron-targeting vaccine by fourth quarter
July 05, 2022 at 14:12 PM EDT
Biotech company Novavax said it expects to be able to provide an Omicron-targeting vaccine in the fourth quarter of this year. Its vaccine is under FDA review.
